drugset / Trial / NCT03753477

Clinical Trial to Investigate the Efficacy and Safety of DWJ1351

NCT03753477

Phase 1 Completed 64 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to compare the safety and pharmacokinetic characteristics of combination of amlodipine, olmesartan and rosuvastatin and DWJ1351 in healthy male volunteers

Timeline

Start
2017-12-22
Primary completion
2018-01-26
Completion
2018-02-01

Drugs

EvaluationDrugModalityDoseRoute
Subject DWJ1351 Unknown
Comparator Rosuvastatin Small molecule
Comparator Sevikar Unknown

Indications

No indication recorded.